We Develop Treatments For Concussion And Other Neurological Disorders

Odyssey Health, Inc. is a unique, medical device technology holding company, publicly traded on the OTC under the ticker ODYY. We develop and acquire life saving medical products with a technological and clinical advantage.

  • Loading stock data...

Odyssey Health is developing PRV-002, a novel neurosteroid for the treatment of concussion.

Find out more
CLICK HERE: NFL Legend Brett Favre Involved With Melbourne Trials Of World-First Concussion TreatmentCLICK HERE: Interview With Brett Favre Discussing Concussions On SEN

We Build and Acquire assets in medical technologies with a substantial market opportunity across the globe.

The Company’s product technologies are diverse, there are three different medical products in development. The Company has two devices being designed for large market segments, one for the cardiology market and one for a home use choking rescue devices. The Company has also partnered with Prevacus, Inc., who has been developing a nasal spray to treat concussions and other brain related medical issues such as Nieman Picks type C disease.

Get the latest information on Odyssey Health, Inc. (OTC: ODYY) and its filings.

Odyssey Health, Inc. is always acquiring distinct assets, intellectual property, and technologies.

Learn more about Odyssey Health, Inc. and its dynamic management team.

Contact Us

Please fill in the form and we will get back to you.

Odyssey Health, Inc.
2372 Morse Avenue
Irvine, CA 92614

Local: 702-780-6559

Toll-free: 844-368-9663

E-mail: info@odysseygi.com